Molecular Biomarkers of Primary and Acquired Resistance to T‐Cell‐Mediated Immunotherapy in Cancer: Landscape, Clinical Implications, and Future Directions

The emergence of immunotherapy has revolutionized cancer treatment in recent years. Inhibitors of immune checkpoints, including antibodies against cytotoxic T‐lymphocyte‐associated protein 4, programmed cell death protein 1, and programmed death ligand 1, have demonstrated notable efficacy in certai...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Oncologist
Autores principales: Chae, Young Kwang, Oh, Michael S., Giles, Francis J.
Formato: Artigo
Lenguaje:Inglês
Publicado: AlphaMed Press 2017
Materias:
Cancer Diagnostics and Molecular Pathology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5896702/
https://ncbi.nlm.nih.gov/pubmed/29242279
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0354
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares